Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 19/20 | 0.50 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.43 |
| ▸ | CDK2 | P24941 | 1/20 | 0.43 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4778989 | 0.89 | KDM4E (0.49) | TRPV1CCNE1CDK2CDK5 | |
| SCHEMBL4780425 | 0.89 | TRPV1 (0.49) | TRPV1CCNE1CDK2CDK5 | |
| SCHEMBL4778931 | 0.85 | TRPV1 (0.55) | TRPV1CCNE1CDK2CDK5 | |
| SCHEMBL4778207 | 0.82 | TRPV1 (0.49) | TRPV1CCNE1CDK2CDK5 | |
| SCHEMBL4778224 | 0.82 | TRPV1 (0.53) | TRPV1CCNE1CDK2CDK5 | |
| SCHEMBL4774396 | 0.82 | TRPV1 (0.49) | TRPV1CCNE1CDK2CDK5 | |
| SCHEMBL4781101 | 0.81 | EPHX2 (0.51) | TRPV1 | |
| SCHEMBL4779566 | 0.81 | TRPV1 (0.50) | TRPV1CCNE1CDK2CDK5 | |
| SCHEMBL4777147 | 0.80 | TRPV1 (0.52) | TRPV1 | |
| SCHEMBL4779260 | 0.80 | TRPV1 (0.52) | TRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008010061-A2 | 3-AZABICYCLO [3.1.0] HEXANE VANILLOID RECEPTOR LIGANDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PROCESSES FOR THEIR PREPARATION | GLENMARK PHARMACEUTICALS S.A. (US) | 2008-01-24 | — | — | WO | claimed |
| WO-2008010061-A2 | 3-AZABICYCLO [3.1.0] HEXANE VANILLOID RECEPTOR LIGANDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PROCESSES FOR THEIR PREPARATION | GLENMARK PHARMACEUTICALS S.A. (US) | 2008-01-24 | — | — | WO | disclosed |